Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review
Fariba Peytam, Zahra Emamgholipour, Ali Mousavi, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106831-106831
Closed Access | Times Cited: 12

Showing 12 citing articles:

Synthesis and Anti-acute Myeloid Leukemia Activity of Cyclopropane-1,1-diamide Derivatives Containing Imidazo[1,2-a]pyridine
L. Eduardo Wu, Jiangdong Li, Zhonghua Shi, et al.
Chinese Journal of Organic Chemistry (2025) Vol. 45, Iss. 1, pp. 286-286
Closed Access
Recent advancements in metal-free C–C bond formation via C–H bond functionalization
A. K. Sikder, Jhimli Sengupta
Organic & Biomolecular Chemistry (2025)
Closed Access
Imidazopyridine Family: Versatile and Promising Heterocyclic Skeletons for Different Applications
Giorgio Volpi, Enzo Laurenti, Roberto Rabezzana
Molecules (2024) Vol. 29, Iss. 11, pp. 2668-2668
Open Access | Times Cited: 4
Frustrated Lewis pairs in two-dimensional borocarbonitride for the facile synthesis of 3-aminoimidazo[1,2-α]pyridines using TMSCN as an isonitrile substitute
Jing Leng, Mohd Sajid Ali, Hamad A. Al‐Lohedan, et al.
New Journal of Chemistry (2024) Vol. 48, Iss. 13, pp. 5971-5980
Closed Access | Times Cited: 2
Imidazopyrimidine: from a relatively exotic scaffold to an evolving structural motif in drug discovery
Moumita Ghosh Chowdhury, Vaishnavi Kalmegh, Saumya Kapoor, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1488-1507
Closed Access | Times Cited: 2
Targeted suppression of oral squamous cell carcinoma by pyrimidine-tethered quinoxaline derivatives
Asmita Choithramani, Rudradip Das, Gourav Bothra, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 8, pp. 2729-2744
Closed Access | Times Cited: 2
Exploring the untapped pharmacological potential of imidazopyridazines
M. Shaheer Malik, Hossa F. Al-Shareef, Khalid A. Alfaidi, et al.
RSC Advances (2024) Vol. 14, Iss. 6, pp. 3972-3984
Open Access | Times Cited: 1
Synthesis of Imidazo[1,2‐b]pyridazine Scaffold Based Amide Derivatives as Potential Inhibitors for Bacterial Activity
Neelam Yesubabu, Dodda Bhargavi, Jyothi Prashanth, et al.
ChemistrySelect (2024) Vol. 9, Iss. 19
Closed Access
Characterization and Optimization of the Photoluminescent Properties of Imidazo[1,5‐a]quinolines
Niclas Kulhanek, Kateryna V. Borysova, M.T. Kirchner, et al.
European Journal of Organic Chemistry (2024)
Open Access
Micelle-Assisted C(sp2)–H Functionalization for C–Se and C–X Bond Formation in the Aqueous Medium
Abhinay S. Chillal, Chandra B Maurya, Umesh A. Kshirsagar
Langmuir (2024) Vol. 40, Iss. 44, pp. 23445-23457
Closed Access
Structure-Based QSAR Modeling of RET Kinase Inhibitors from 49 Different 5,6-Fused Bicyclic Heteroaromatic Cores to Patent-Driven Validation
Sumin Jin, Surendra Kumar, Mi‐Hyun Kim
ACS Omega (2024) Vol. 9, Iss. 50, pp. 49662-49673
Closed Access
Synthesis of 2,2a1,6-Triazaaceanthrylenes
Jan Radolko, Karyna Kulyk, Peter Ehlers, et al.
Tetrahedron Letters (2023) Vol. 134, pp. 154834-154834
Closed Access
Page 1

Scroll to top